TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 32128716

Group type: EXPERIMENTAL
Intervention: Active play (3 hours)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sedentary screen time (3 hours)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Sedentary screen time
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: High-calorie food pictures
Number of subjects: 32

Group type: EXPERIMENTAL
Intervention: Hunger measurement
Number of subjects: 32
Study: 35950949

Group type: EXPERIMENTAL
Intervention: Three-monthly viral load testing and sequential point-of-care drug exposure testing and DBS-based drug resistance testing in case of rebound above 1000 copies/ml
Number of subjects: 501

Group type: COMPARATOR
Intervention: Standard-of-care monitoring according to WHO guidelines
Number of subjects: 501

Group type: EXPERIMENTAL
Intervention: Three-monthly viral load testing
Number of subjects: 501

Group type: COMPARATOR
Intervention: Standard-of-care annual viral load testing
Number of subjects: 501
Study: 34473405

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: Oral pre-exposure prophylaxis (PrEP)
Number of subjects: 110

Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST) and Oral pre-exposure prophylaxis (PrEP)
Number of subjects: 110
Study: 35329390

Group type: EXPERIMENTAL
Intervention: Physiotherapy program to train strength and coordination of the masticatory muscles, details on dosage and duration not available.
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Novel methodology for recruitment process for people with dementia, details not available.
Number of subjects: 0
Study: 34406856

Group type: EXPERIMENTAL
Intervention: mPalliative Care Link (mPCL)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Phone-contact POS collection
Number of subjects: 98
Study: 36119062

Group type: EXPERIMENTAL
Intervention: BK-SE36 (intramuscular route)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: BK-SE36 (subcutaneous route)
Number of subjects: 108

Group type: COMPARATOR
Intervention: Control vaccine (Synflorix® via IM route)
Number of subjects: 108

Group type: EXPERIMENTAL
Intervention: BK-SE36 (both routes)
Number of subjects: 108
Study: 34719267

Group type: EXPERIMENTAL
Intervention: Good cartilage status (ICRS grade I or II; n = 70)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Poor cartilage status (ICRS grade III or IV; n = 85)
Number of subjects: 155
Study: 32633993

Group type: EXPERIMENTAL
Intervention: pCS20 quantitative polymerase chain reaction (qPCR) assay
Number of subjects: 3792

Group type: EXPERIMENTAL
Intervention: Sequencing of positive samples
Number of subjects: 3792

Group type: EXPERIMENTAL
Intervention: Phylogenetic analysis
Number of subjects: 3792

Group type: EXPERIMENTAL
Intervention: Propagation in cell cultures
Number of subjects: 3792
Study: 35434945

Group type: EXPERIMENTAL
Intervention: Okra whole fruit capsules (1,000 mg) taken orally every 6 hours for 8 weeks
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo capsule taken orally every 6 hours for 8 weeks
Number of subjects: 120
Study: 33764191

Group type: EXPERIMENTAL
Intervention: Physicians' expressed beliefs to patients about poor prognoses
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Physicians' expressed beliefs to patients about prognoses
Number of subjects: 398

Group type: EXPERIMENTAL
Intervention: Reasons for differences in beliefs
Number of subjects: 398
Study: 32252101

Group type: EXPERIMENTAL
Intervention: Caffeine (5 mg/kg BM)
Number of subjects: 8

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 8
Study: 34580053

Group type: EXPERIMENTAL
Intervention: Screening with prostate-specific antigen (PSA) followed by magnetic resonance imaging (MRI)
Number of subjects: 61201
Study: 33298001

Group type: EXPERIMENTAL
Intervention: Group-based training along with text messaging
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: CD-based training
Number of subjects: 75

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 75
Study: 35337312

Group type: EXPERIMENTAL
Intervention: Face-to-face training for 6 hours with slides, lectures, and practical work on intubation, LMA, CPR, and AED.
Number of subjects: 87

Group type: COMPARATOR
Intervention: Virtual training using a training video on CD with full explanation of project objectives.
Number of subjects: 87
Study: 34365019

Group type: EXPERIMENTAL
Intervention: High-Frequency Left (HFL)
Number of subjects: 414

Group type: EXPERIMENTAL
Intervention: intermittent theta burst stimulation (iTBS)
Number of subjects: 414
Study: 32362221

Group type: EXPERIMENTAL
Intervention: Modified quadruple therapy (rabeprazole 20 mg bid, amoxicillin 1 g bid, metronidazole 500 mg tid, bismuth subcitrate 300 mg qid)
Number of subjects: 233

Group type: COMPARATOR
Intervention: Bismuth-containing quadruple therapy (rabeprazole 20 mg bid, bismuth subcitrate 300 mg qid, metronidazole 500 mg tid, tetracycline 500 mg qid)
Number of subjects: 233

Group type: EXPERIMENTAL
Intervention: Both therapies
Number of subjects: 233
Study: 34882603

Group type: EXPERIMENTAL
Intervention: Clinical refractions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Pupil fraction tessellated refractions
Number of subjects: 30

Group type: EXPERIMENTAL
Intervention: Visual Strehl ratio refractions
Number of subjects: 30
Study: 33235122

Group type: EXPERIMENTAL
Intervention: Arthroscopic repair with platelet-rich plasma (PRP)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Arthroscopic repair without platelet-rich plasma (Control)
Number of subjects: 0
Study: 36011825

Group type: EXPERIMENTAL
Intervention: Binaural beat audio
Number of subjects: 61

Group type: COMPARATOR
Intervention: Sham-control (ear phones with no music)
Number of subjects: 61
Study: 33250383

Group type: EXPERIMENTAL
Intervention: Active tDCS
Number of subjects: 59

Group type: COMPARATOR
Intervention: Sham
Number of subjects: 59
Study: 36228195

Group type: EXPERIMENTAL
Intervention: Cotadutide
Number of subjects: 0
Study: 33347732

Group type: EXPERIMENTAL
Intervention: Music therapy by passive listening to music for 30 minutes/day, 5 days/week for 4 weeks, along with DASH eating plan
Number of subjects: 30

Group type: COMPARATOR
Intervention: DASH eating plan and sodium restriction
Number of subjects: 30
Study: 32433709

Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 2 (0.54-0.92 μg/L)
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 3 (0.93-1.62 μg/L)
Number of subjects: 1008

Group type: EXPERIMENTAL
Intervention: Blood cadmium quartile 4 (1.63-57.81 μg/L)
Number of subjects: 1008

Group type: COMPARATOR
Intervention: Lowest blood cadmium quartile (0.00-0.53 μg/L)
Number of subjects: 1008
Study: 35443242

Group type: EXPERIMENTAL
Intervention: Noncorrection (N)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Threshold difference (A1)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Regression equation (A2)
Number of subjects: 66
Study: 32019509

Group type: EXPERIMENTAL
Intervention: Group cognitive behavioural therapy (GCBT) plus treatment as usual (TAU)
Number of subjects: 112

Group type: COMPARATOR
Intervention: Waiting list (WL) plus treatment as usual (TAU)
Number of subjects: 112
Study: 35505452

Group type: EXPERIMENTAL
Intervention: Topical anesthesia pretreatment with lidocaine‐prilocaine cream (EMLA)
Number of subjects: 62

Group type: COMPARATOR
Intervention: Water‐based cream (placebo)
Number of subjects: 62
Study: 33433024

Group type: EXPERIMENTAL
Intervention: Mobile phone application (app) for central venous catheter care (n = 39)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Control condition (n = 40)
Number of subjects: 90
Study: 33278747

Group type: EXPERIMENTAL
Intervention: Pentoxifylline 400 mg t.i.d. plus standard therapy
Number of subjects: 38

Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 38
Study: 32564236

Group type: EXPERIMENTAL
Intervention: Prehabilitation (13–17-week telephone-guided graduated walking programme)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 44

Group type: COMPARATOR
Intervention: Prehabilitation vs Control
Number of subjects: 44
Study: 34647992

Group type: EXPERIMENTAL
Intervention: Filgotinib 200 mg once daily for 12 weeks
Number of subjects: 116

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 116
Study: 33927155

Group type: EXPERIMENTAL
Intervention: Lidocaine buffered with sodium bicarbonate
Number of subjects: 199

Group type: COMPARATOR
Intervention: Lidocaine alone
Number of subjects: 199

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 199
Study: 32377822

Group type: EXPERIMENTAL
Intervention: Simvastatin treatment for non-infectious uveitis
Number of subjects: 50
Study: 36387983

Group type: EXPERIMENTAL
Intervention: Optimized pharmacotherapy (OPT) with nicotine patch and up to two adaptations to varenicline and bupropion based on smoking status
Number of subjects: 392

Group type: COMPARATOR
Intervention: Enhanced usual care (UC) with nicotine patch throughout treatment
Number of subjects: 392
Study: 32036988

Group type: EXPERIMENTAL
Intervention: Dietary 0.06% Cl due to complete substitution of NaCl by Na2SO4
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Dietary Cl levels at 0.10% and 0.15%
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Dietary 0.10% and 0.15% Cl
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Dietary 0.15% Cl
Number of subjects: 360

Group type: EXPERIMENTAL
Intervention: Na2SO4 partly replacing NaCl in diets
Number of subjects: 360
Study: 35620956

Group type: EXPERIMENTAL
Intervention: High-Intensity Circuit Training using Body Weight (HICTBW)
Number of subjects: 24
Study: 33154431

Group type: EXPERIMENTAL
Intervention: N75P13K25 + microbial consortium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N150P26K50 + microbial consortium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Reduction of 50% NPK with microbial consortium
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: N150P26K50 with microbial consortium
Number of subjects: 0
Study: 33682454

Group type: EXPERIMENTAL
Intervention: Admission IL-6 levels
Number of subjects: 552

Group type: COMPARATOR
Intervention: Treatment group
Number of subjects: 552
Study: 32998771

Group type: EXPERIMENTAL
Intervention: More than 5 N1 LNs examined
Number of subjects: 2028

Group type: COMPARATOR
Intervention: 0-5 N1 LNs examined
Number of subjects: 2028
Study: 34904800

Group type: EXPERIMENTAL
Intervention: Ketamine (0.5mg/kg)
Number of subjects: 53

Group type: EXPERIMENTAL
Intervention: Esketamine (0.25mg/kg)
Number of subjects: 53
Study: 33535274

Group type: EXPERIMENTAL
Intervention: Training B (3 directions, 3 minutes duration)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Everyday training (Training B)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Once-a-week training (Training B)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Every-other-day training (Training B)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Control group (no training)
Number of subjects: 48
Study: 32999003

Group type: EXPERIMENTAL
Intervention: Intraepithelial CD8+ cell density
Number of subjects: 695

Group type: EXPERIMENTAL
Intervention: Machine-learning, image-based algorithm for quantifying immune cell density
Number of subjects: 695
Study: 36331493

Group type: EXPERIMENTAL
Intervention: IUI with ovarian stimulation (IUI-OS)
Number of subjects: 178

Group type: COMPARATOR
Intervention: Expectant management (EM)
Number of subjects: 178
Study: 33341062

Group type: EXPERIMENTAL
Intervention: Virtual auscultation teaching strategy (3 sessions, 2 hours each)
Number of subjects: 127

Group type: COMPARATOR
Intervention: Usual preparation in auscultation learning strategies
Number of subjects: 127
Study: 33169787

Group type: EXPERIMENTAL
Intervention: Chromoendoscopy (CE)
Number of subjects: 129

Group type: COMPARATOR
Intervention: Virtual Chromoendoscopy (VC)
Number of subjects: 129
Study: 32171774

Group type: EXPERIMENTAL
Intervention: Levothyroxine (starting dose of 50 µg daily)
Number of subjects: 185

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 185
Study: 36494824

Group type: EXPERIMENTAL
Intervention: Theory-informed intervention including co-designed information videos and posters, in-house staff vaccination clinics, and an incentive scheme.
Number of subjects: 39

Group type: COMPARATOR
Intervention: Usual practice (control group) with additional monthly data contribution.
Number of subjects: 39

Group type: EXPERIMENTAL
Intervention: Theory-informed intervention
Number of subjects: 39
Study: 33721874

Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by <90% baseline for left Scto2
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by <85% baseline for right Scto2
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Minimum Scto2
Number of subjects: 175

Group type: EXPERIMENTAL
Intervention: Cerebral desaturation defined by other thresholds, cerebral hypersaturation, AUT/AAT, and somatic desaturation and hypersaturation
Number of subjects: 175
Study: 32795294

Group type: EXPERIMENTAL
Intervention: Intervention group (6 group education sessions to promote healthy eating)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Control group (usual nutritional consultation)
Number of subjects: 177

Group type: COMPARATOR
Intervention: Difference in HOMA‐IR between control and intervention group
Number of subjects: 177
Study: 32431191

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.1% ointment once a day (QD)
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Topical tacrolimus 0.1% ointment once every two days (QOD)
Number of subjects: 40
Study: 33987839

Group type: EXPERIMENTAL
Intervention: Disaster preparedness education intervention
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 0
Study: 35459668

Group type: EXPERIMENTAL
Intervention: Hyperbaric oxygen therapy (HBOT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham-HBOT
Number of subjects: 80
Study: 33470195

Group type: EXPERIMENTAL
Intervention: Bempedoic acid 180 mg daily
Number of subjects: 14014

Group type: COMPARATOR
Intervention: Matching placebo
Number of subjects: 14014
Study: 33251500

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine plus Azithromycin (HC+AZ)
Number of subjects: 456

Group type: EXPERIMENTAL
Intervention: Hydroxychloroquine (HC)
Number of subjects: 456

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 456
Study: 36111559

Group type: EXPERIMENTAL
Intervention: GIP infusion (6 pmol/kg/min)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 20
Study: 33352588

Group type: EXPERIMENTAL
Intervention: ENT Learning Program (online learning platform)
Number of subjects: 116
Study: 32673226

Group type: EXPERIMENTAL
Intervention: EmotionRegulation
Number of subjects: 214

Group type: COMPARATOR
Intervention: Treatment as Usual (TAU)
Number of subjects: 214
Study: 35514022

Group type: EXPERIMENTAL
Intervention: Transdermal testosterone (maximum dose 40 mg/daily)
Number of subjects: 69

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 69
Study: 33478397

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D2 supplementation (60,000 IU/week for 12 weeks)
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-dose vitamin D2 supplementation (20,000 IU/week for 12 weeks)
Number of subjects: 140

Group type: EXPERIMENTAL
Intervention: High-dose vitamin D2 supplementation
Number of subjects: 140

Group type: COMPARATOR
Intervention: Low-dose vitamin D2 supplementation
Number of subjects: 140
Study: 33148023

Group type: EXPERIMENTAL
Intervention: YAG laser vitreolysis
Number of subjects: 24

Group type: COMPARATOR
Intervention: Control group
Number of subjects: 24
Study: 32232434

Group type: EXPERIMENTAL
Intervention: Skilful Care Training Package (SCTP) delivered by physiotherapists to care staff
Number of subjects: 146

Group type: COMPARATOR
Intervention: Usual Care (UC)
Number of subjects: 146
Study: 35258035

Group type: EXPERIMENTAL
Intervention: Adalimumab + risperidone
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo + risperidone
Number of subjects: 40
Study: 32417993

Group type: EXPERIMENTAL
Intervention: Sorafenib dose interruption
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sorafenib dose reduction
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sorafenib discontinuation
Number of subjects: 0

Group type: COMPARATOR
Intervention: Control group (no AEs requiring dose adjustment)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Sorafenib treatment
Number of subjects: 0
Study: 35754690

Group type: EXPERIMENTAL
Intervention: Tai chi
Number of subjects: 50

Group type: COMPARATOR
Intervention: Self‐monitored exercise
Number of subjects: 50
Study: 33682367

Group type: EXPERIMENTAL
Intervention: UL-Tea (3 doses/day of catechin-rich green tea)
Number of subjects: 12

Group type: COMPARATOR
Intervention: UL-Placebo (placebo control)
Number of subjects: 12
Study: 32859433

Group type: EXPERIMENTAL
Intervention: Laparoscopic radical hysterectomy (LRH)
Number of subjects: 1509

Group type: COMPARATOR
Intervention: Abdominal radical hysterectomy (ARH)
Number of subjects: 1509
Study: 32552562

Group type: EXPERIMENTAL
Intervention: Incentive appeals highlighting microbiome benefits
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Causal analysis, latent class analysis, and equilibrium values for transition matrices
Number of subjects: 298
Study: 34342588

Group type: EXPERIMENTAL
Intervention: Predictive lung cancer screening model using electronic medical records and neural networks
Number of subjects: 1417711
Study: 32208783

Group type: EXPERIMENTAL
Intervention: CoMFA‐INDX model for GT1a
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: CoMSIA‐SEHA model for GT1a Y93H
Number of subjects: 196

Group type: EXPERIMENTAL
Intervention: CoMSIA‐SEHA model for GT1a L31V
Number of subjects: 196
Study: 35475796

Group type: EXPERIMENTAL
Intervention: Bailing capsule (BLC)
Number of subjects: 0
Study: 33097932

Group type: COMPARATOR
Intervention: Soy food intake 1 time/week
Number of subjects: 24622

Group type: COMPARATOR
Intervention: Soy food intake 2-3 times/week
Number of subjects: 24622

Group type: COMPARATOR
Intervention: Soy food intake ≥4 times/week
Number of subjects: 24622

Group type: COMPARATOR
Intervention: Energy-adjusted soy food intake (grams per 1000 kilocalories) quartiles
Number of subjects: 24622
Study: 35123483

Group type: EXPERIMENTAL
Intervention: Tofogliflozin
Number of subjects: 337

Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 337
Study: 33140428

Group type: EXPERIMENTAL
Intervention: Collagen sponge with sutures (SG)
Number of subjects: 36

Group type: COMPARATOR
Intervention: Collagen sponge without sutures (nSG)
Number of subjects: 36
Study: 35537570

Group type: EXPERIMENTAL
Intervention: Fixed-NSA prosthesis
Number of subjects: 50

Group type: COMPARATOR
Intervention: Variable-NSA prosthesis
Number of subjects: 50
Study: 33675460

Group type: EXPERIMENTAL
Intervention: Nicotine gum (4-mg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Nicotine gum (2-mg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo gum
Number of subjects: 13
Study: 32129962

Group type: EXPERIMENTAL
Intervention: 650-microsecond, 1064-nm pulsed YAG laser
Number of subjects: 15

Group type: COMPARATOR
Intervention: 308-nm excimer laser
Number of subjects: 15
Study: 34117519

Group type: EXPERIMENTAL
Intervention: Myeloablative conditioning (MAC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Reduced intensity conditioning (RIC)
Number of subjects: 80
Study: 32379777

Group type: EXPERIMENTAL
Intervention: Glyburide treatment
Number of subjects: 914
Study: 34696774

Group type: EXPERIMENTAL
Intervention: Tight glucose control
Number of subjects: 3448

Group type: COMPARATOR
Intervention: Liberal glucose control
Number of subjects: 3448
Study: 32285479

Group type: EXPERIMENTAL
Intervention: Visible ovarian follicles at the newborn visit (n=133)
Number of subjects: 163

Group type: EXPERIMENTAL
Intervention: Overall ovarian growth trajectory
Number of subjects: 163
Study: 33974467

Group type: EXPERIMENTAL
Intervention: Tiotropium
Number of subjects: 3
Study: 34939917

Group type: EXPERIMENTAL
Intervention: Special training for primary care physicians
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Special training for the entire practice team
Number of subjects: 1138

Group type: COMPARATOR
Intervention: Control group with general instructions about medication
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Any intervention (69 practices)
Number of subjects: 1138

Group type: EXPERIMENTAL
Intervention: Team training (35 practices)
Number of subjects: 1138
Study: 35345256

Group type: EXPERIMENTAL
Intervention: Exogenous phosphocreatine (PCr)
Number of subjects: 105

Group type: COMPARATOR
Intervention: Control (routine hydration therapy)
Number of subjects: 105
Study: 33677189

Group type: EXPERIMENTAL
Intervention: Liraglutide 3.0 mg
Number of subjects: 16
Study: 33916366

Group type: EXPERIMENTAL
Intervention: Intermittent Calorie Restriction (ICR) - 5:2 diet (100% energy intake on 5 non-restricted days, 25% on 2 restricted days)
Number of subjects: 98

Group type: COMPARATOR
Intervention: Continuous Calorie Restriction (CCR) - daily energy intake of 80%
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: Intermittent Calorie Restriction (ICR)
Number of subjects: 98
Study: 35109140

Group type: EXPERIMENTAL
Intervention: High-dose TG-DHA supplementation (2,040 mg DHA daily for six months)
Number of subjects: 28
Study: 32576901

Group type: COMPARATOR
Intervention: CTPA using the test bolus approach with 20 ml contrast agent at 100 kVp
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CTPA using the biphasic time-enhancement curves approach with 10 ml contrast agent at 80 kVp
Number of subjects: 70

Group type: COMPARATOR
Intervention: CTPA using the test bolus approach
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: CTPA using the optimized protocol
Number of subjects: 70
Study: 35991062

Group type: EXPERIMENTAL
Intervention: Music-based casual video game training for 4 weeks
Number of subjects: 56

Group type: COMPARATOR
Intervention: Daily life activities without any intervention (Control)
Number of subjects: 56
Study: 32109215

Group type: EXPERIMENTAL
Intervention: Valganciclovir Valganciklovir Teva® (VT group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Alvanocyte® (A group)
Number of subjects: 66

Group type: EXPERIMENTAL
Intervention: Valcyte® (V group)
Number of subjects: 66
Study: 35171954

Group type: EXPERIMENTAL
Intervention: Dietary supplement containing a mixture of Boswellia serrata Roxb., chlorophyll, green tea extract, glucosamine, chondroitin sulfate, hyaluronic acid, and non-hydrolised type II collagen for 60 days
Number of subjects: 40

Group type: COMPARATOR
Intervention: Placebo for 60 days
Number of subjects: 40
Study: 35221681

Group type: EXPERIMENTAL
Intervention: Stay Active at Home (SAaH) training program
Number of subjects: 264

Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 264